Ajayi, A A <br/><br/>
Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.  [electronic resource] 

 -  Diabetes research and clinical practice  Mar 2004 
 - 155-69 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2003.09.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology<br/>Acetylcholine--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Flow Velocity--drug effects<br/>Blood Pressure--drug effects<br/>Diabetes Mellitus, Type 2--complications<br/>Drug Interactions<br/>Endothelin A Receptor Antagonists<br/>Endothelin B Receptor Antagonists<br/>Endothelin-1--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Hypertension--complications<br/>Kidney Cortex--blood supply<br/>Kidney Medulla--blood supply<br/>Male<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Oligopeptides--pharmacology<br/>Piperidines--pharmacology<br/>Platelet Aggregation--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Zucker<br/>Receptor Cross-Talk<br/>Receptor, Endothelin A--drug effects<br/>Receptor, Endothelin B--drug effects<br/>Receptors, Endothelin--drug effects<br/>Thromboxane A2--pharmacology